Successful results from trial of first-in-class Parkinson’s disease peptide
Researchers uncover how neurons deliver RNA where it is needed
Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly
Amgen reveals cardiovascular drug results
Pila Pharma’s capital raise oversubscribed by 293% to fund obesity studies